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Aim:We investigated the role of induced endothelial cells (iECs) in mesenchymal stem cells (MSCs)/iECs co-
culture and assessed their osteogenic ability on silk fibroin nanofiber scaffolds. Methods: The osteogenic
differentiation was assessed by the ALP assay, calcium assay and gene expression studies. Results: The os-
teogenic differentiation of the iECs co-cultures was found to be higher than theMSCs group and proximal
to endothelial cells (ECs) co-cultures. Furthermore, the usage of isogenic iECs for co-culture increased the
osteogenic and endothelial gene expression. Conclusion: These findings suggest that iECs mimic endothe-
lial cells when co-cultured with MSCs and that one MSCs source can be used to give rise to both MSCs and
iECs. The isogenic MSCs/iECs co-culture provides a new option for bone tissue engineering applications.
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Background
Mesenchymal stem cells (MSCs) can self renew, proliferate and differentiate into multiple lineages. This makes them
a promising candidate for cell-based therapies in tissue engineering. They can be isolated from different sources
and differentiated into several lineages under suitable induction conditions, especially to osteogenic, adipogenic,
myogenic and chondrogenic differentiation [1].
The umbilical cord is an attractive source for the isolation of MSCs because of abundance, fewer ethical concerns
unlike embryonic stem cells, and ease of culture [2]. Umbilical cord MSCs (UCMSCs) propose to be a promising
source of MSCs that can be thawed, expanded and stored in cell banks for therapeutic applications at the time of
need [3].
Enhanced osteogenic differentiation can be achieved by various methods such as stimulation using chemi-
cal supplements [4,5], electrical stimulation [6,7], bioreactor stimulation [8,9] and co-culture with endothelial cells
(ECs) [10,11]. Use of MSCs–ECs co-culture, with osteogenic supplements, is an effective tool to achieve osteogenic
differentiation. It is known that the presence of ECs with MSCs has a profound effect on their proliferation, differ-
entiation, cell fate, and their resultant angiogenesis and osteogenesis [4]. Several reports have suggested co-culturing
of MSCs and ECs together for enhanced osteogenic differentiation as compared with MSC monocultures [5–7].
Meinel et al. reported enhanced bone formation potential when MSCs were predifferentiated toward osteoblas-
tic lineage [8]. Binder and group also reported increased cell survival when cells were precultured in osteogenic
medium [9]. There are also reports suggesting that bone morphogenetic protein-2 synthesized by ECs increases the
osteogenic differentiation in co-culture [12]. However, the ECs isolated from large blood vessels have low prolifera-
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tion rate and are likely to de-differentiate in culture after prolonged expansion [10,11]. Also, autologous isolation of
these ECs requires sacrificing a vessel of the patient [13]. In addition, getting both the cell types (MSCs and ECs)
from autologous source is much challenging than any single cell type.
To overcome these limitations and to avoid the ethical concerns of using two different cell types, the ability of
MSCs to differentiate into endothelial phenotype is investigated. In the initial phase of vascular development, ECs
in the embryo are obtained through in situ differentiation of the multipotent mesodermal progenitor cells [14,15].
Corotchi et al. proved that culture conditions and isolation procedures could lead to various cell lineages, starting
with the same MSCs derived from Wharton’s jelly. They also reported a cell population that co-expressed mes-
enchymal and EC markers [16]. MSCs have been reported to differentiate into endothelial lineage by many other
groups as well [17–19]. These particular kind of cells obtained by endothelial differentiation of MSCs are induced
ECs (iECs). iECs were found to stimulate in vitro differentiation of bone marrow MSCs (BM-MSCs) and stimulate
osteogenesis in vivo by direct contact with BM-MSCs [20]. It was also reported that BM-MSCs offered new choices
for engineering of artificial tissues based on autologous MSCs and vascularized engineered tissues [21].
The therapeutic potential of the MSCs-ECs co-culture has been hampered due to lack of appropriate structural
scaffolds supporting these cell types. Hence, silk-based scaffolds have been selected for this study. The application
of silk-based biomaterials has been proved to be beneficial for bone regeneration because of their low inflammatory
potential, excellent biocompatibility and ability to degrade in vivo entirely within 2–6 months [22]. Several studies
have reported the use of electrospun silk fibroin (SF) nanofiber scaffolds (SFNS) in bone tissue engineering [16,23,24].
It has been proved that electrospun SFNS augment the osteogenic differentiation of MSCs and bone formation in
bone defect models [25].
The rationale behind our study is to use one single cell source in a modified form for osteogenic MSC–EC
co-culture system. Since UCMSCs have been shown to differentiate into the endothelial lineage [26], we have used
these cells to obtain both the co-culture cell types, that is, MSCs and ECs. In this study, we intend to compare
the osteogenic ability of iECs-based MSCs/iECs co-cultures with MSC monoculture and ECs-based MSCs/ECs
co-culture. iECs can be used as a substitute for ECs for co-culture with MSC to induce osteogenic differentiation.
Hence, cells from the same MSC source can be replaced in place of ECs, which need two separate cell sources
paving the way for the use of autologous MSCs in co-cultures. The hypothesis of this study is twofold: first, that
iECs can mimic the role of ECs in MSCs–iECs co-culture on SFNS; second, that MSCs–iECs co-culture can show
enhanced osteogenic differentiation than MSC monoculture on SFNS.
Methods
Isolation & cell culture
The umbilical cord was collected from the patient after informed consent. UCMSCs were obtained using tissue
explant method [27]. Under sterile conditions, the cord was washed thoroughly with phosphate-buffered saline
(PBS) to remove blood. With a sterile scalpel, the umbilical cord was cut into small pieces of about 5 mm3 and
placed at an equal distance in a petri plate. The explants were left undisturbed for 5 min until attachment onto the
plate. They were grown in DMEM containing 10% fetal bovine serum, 2-mM L-glutamine and 1% penicillin–
streptomycin, and maintained at 37◦C and 5% CO2. The explants were left undisturbed for 4 days and media
were changed twice weekly after that. After subculture, the medium was replaced with cytomix (Miltenyi Biotec
GmbH, Germany). Human umbilical vein ECs (HUVECs) were purchased from Lonza (MD, USA) and grown
in EC growth medium-2 (EGM-2, Promocell, Germany) at 37◦C and 5% CO2. PBS, DMEM and penicillin–
streptomycin were purchased from Sigma-Aldrich (MO, USA); and L-glutamine and fetal bovine serum were
purchased from Gibco (CA, USA).
Endothelial differentiation of UCMSCs
Endothelial differentiation was performed as described previously [10]. UCMSCs were seeded at a density of
10,000 cells/cm2 and grown in EGM-2 (Promocell) for 12 days. The medium was changed twice weekly for iECs.
Then, the iECs were co-cultured with MSCs and induced osteogenically in osteogenic medium containing 10-mM
β-glycerophosphate (Sigma-Aldrich), 100 nM dexamethasone (HiMedia, India), and 50-μg/ml L-ascorbic acid
(HiMedia).
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Characterization of UCMSCs & iECs
UCMSCs demonstrated trilineage (osteogenic, adipogenic and chondrogenic) differentiation. As recommended
by the International Society for Cellular Therapy, UCMSCs were analyzed for MSC markers such as CD73,
CD90 and CD105, and non-MSC markers such as CD14, CD20, CD34 and CD45. Flow cytometry analysis was
performed using Attune Acoustic Focusing Cytometer (Applied Biosystems, CA, USA) with the help of human
MSC phenotyping kit (Miltenyi Biotec GmbH, Germany). iECs were assessed for their formation of tube-like
structures on the basement membrane matrix preparation, Matrigel (NY, USA) as performed before [28]. They
were also checked for lectin staining using Fluorescein labeled Lycopersicon Esculentum (Tomato) Lectin (Vector
Laboratories, CA, USA).
Preparation of regenerated silk fibroin solution
As described earlier, SF was prepared using a modified protocol [29]. Briefly, cocoons from Bombyx mori were boiled
in an aqueous solution of 0.02 M Na2CO3, rinsed with ultrapurified water (UPW) and dissolved in 9 M LiBr at
55◦C to obtain a 10% (w/v) solution. The solution was dialyzed (IL, USA; MWCO 3.500 Da) against UPW for
48 h. After the desalination, a second dialysis against a polyethylene glycol 6000 solution (200 g/1.5 l UPW) was
performed to concentrate the SF solution up to 12.5%. SF concentration was determined gravimetrically.
Preparation of silk fibroin nanofiber scaffold by electrospinning
Electrospinning was performed using previously described method [29]. The process was accommodated in a fume
hood flushed with dry air to achieve a relative humidity of 22–28%. SF was blended with poly(ethylene oxide)
(PEO) of 900 kDa to achieve stable, continuous spinning. PEO (5%, w/w) was dissolved in UPW by stirring
for 5 days at room temperature, and the solution filtered through a 5 μm-pore size membrane filter. Then, 2 g
of the PEO solution was mixed with 5 g of 12.5% SF solution by moderate stirring. The PEO–SF solution was
electrospun at a flow rate of 0.8 ml/h using a syringe pump, a syringe with needle, a high voltage power supply
(Fabrimex, Volketswil, Switzerland), and a voltage field of 10–14 kV between the needle and the grounded target
placed at 19 cm from the needle. As target, a cover glass with 13-mm diameter was fixed onto a flat-grounded
metal target of 5 mm diameter to produce nanofibers. The crystallinity of the SFNS was induced by water vapor
treatment [29].
Analysis of SF nanofiber
Electrospun fibers were examined microscopically (Axiovert 35) and images were captured using Axio cam MRc5
(Carl Zeiss, Jena, Germany) digital camera for quantitative analysis of fiber homogeneous deposition. Fiber
deposition and dimensions were analysed by using Image J software (NIH, MD, USA).
Scanning electron microscopy
Scanning electron microscopy (SEM) was used to determine the morphological appearance and diameter of the
SF fibers. Water vapor-treated samples were platinum-coated prior to examination with a LEO 1530 GEMINI
scanning electron microscope (Zeiss, Cambridge, UK). For the analysis of cell-seeded SFNS, composites were fixed
with 3% glutaraldehyde.
Experimental groups
In this study, two cell types: UCMSCs and ECs were used primarily. Endothelial differentiation of UCMSCs for
12 days yielded iECs. ECs were not subject to any differentiation.
In our study, all the cultures were performed on SFNS, which were divided into three groups according to the
cells used (Table 1). The monoculture MSC group was categorized as control, while iEC-based co-culture group
was group B (MSC+iEC) and EC-based co-culture group was group C (MSC+EC). The samples were evaluated
at predefined time points, 1 and 3 weeks. Only week-3 samples were considered for gene expression analysis.
Before seeding cells, the scaffolds were incubated overnight with PBS containing 5% penicillin–streptomycin.
After washing with PBS, scaffolds were exposed to ultra-violet light for 1 h. Subsequently, the scaffolds were coated
with 1 μg/ml of laminin (Sigma-Aldrich) and incubated at 37◦C for 3 h. The scaffolds were washed again with
PBS before proceeding to cell seeding. For the control group, 20,000 MSCs per scaffold were seeded. For the other
two co-culture groups, 10,000 cells of each cell type per scaffold were seeded. Cytomix was used as growth medium
for the control group. For the co-culture groups (groups B and C), 1:1 cytomix-EGM-2 cocktail medium was used.
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Table 1. Experimental groups and study design involving mesenchymal stem cells, endothelial cells, induced endothelial
cells and silk fibroin nanofiber scaffold.
Groups Cell 1 Cell 2 Live–dead assay (n) AlamarBlue assay (n) ALP, Bicinchoninic
acid (BCA) and
calcium assay (n)
RT-qPCR (n)
A (control) MSC – 3 3 3 3
B MSC iEC: endothelially
differentiated from
MSCs
3 3 3 3
C MSC EC 3 3 3 3
BCA: Bicinchoninic acid; EC: Endothelial cell; FITC: Fluorescein isothiocyanate; iEC: Induced endothelial cell; MSC: Mesenchymal stem cell; RT-qPCR: Reverse transcription-quantitative PCR.
After 2 days of culture on scaffolds, the medium was fully replaced with osteogenic medium for all groups. P4-P5
passage cells of all cell types were used for seeding on the silk nanofiber scaffold.
Live–dead assay
Fluorescein diacetate/propidium iodide (FDA/PI) assay was performed as discussed earlier [14]. The cell-scaffold
composites were washed with PBS and stained with 2 μg/ml FDA (Molecular Probes, OR, USA). They were
incubated at 37◦C for 15 min and rinsed again with PBS. Then, the scaffolds were stained with 20 μg/ml PI
(Invitrogen, OR, USA) solution at room temperature for 2 min. After rinsing with PBS, the scaffolds were immersed
in PBS and viewed under a fluorescent microscope (Carl Zeiss Axio Observer Z1). Viable cells were stained with
green color whereas dead cells stained red.
AlamarBlue assay
The cell-seeded SFNS were analyzed by AlamarBlue assay (Invitrogen) as described previously [14]. In short, 10%
AlamarBlue solution was added to the cell-scaffold composites and incubated at 37◦C for 4 h. The absorbance of
the reduced dye was measured using a plate reader (Enspire multimode plate reader, Perkin Elmer, MA, USA) at
570 and 600 nm. The percentage of dye reduction was calculated according to the manufacturer’s protocol.
Differentiation studies
ALP staining & assay
Staining was performed using ALP kit (Sigma-Aldrich) according to the manufacturer’s protocol as discussed
before [14]. In short, cells were fixed with the citrate fixative, and diazonium salt solution was used to stain the
cells. The scaffolds were observed under phase contrast microscope (Olympus, Japan) and images were taken. The
colored complex produced by the hydrolysis of p-nitrophenyl phosphate (Sigma-Aldrich) was measured at 460 nm
absorbance by a microplate reader to assess the ALP content. The values were normalized to total protein, as
measured by the following assay.
BCA assay
The total protein content of the lysates was measured using BCA Protein Assay Kit (Pierce Biotechnology, IL, USA).
The absorbance was measured at 540 nm, as described by the manufacturer and reported before [28]. Total protein
content values were used to normalize the ALP content of the lysates.
Calcium assay & staining
In an alkaline buffer, calcium reacted with o-cresolphthalein, and the developed purple color was measured using
a plate reader (Enspire multimode plate reader, Perkin Elmer) at a wavelength of 570 nm. Calcium deposits were
stained with Alizarin Red solution. Cells were fixed in 10% formalin (Fisher Scientific, India), and 2% Alizarin Red
(HiMedia) was added to the scaffolds. The specimens were observed under phase contrast microscope (Olympus)
and images were taken.
Reverse transcription-quantitative PCR
Osteogenic differentiation in the 3D silk scaffold co-culture for three groups was quantified by reverse transcription-
quantitative PCR (RT-qPCR) analysis. Total RNA from each sample was isolated using TRIzol reagent (Ambion,
Life Technologies, CA, USA) and RNeasy Mini Kit (Qiagen, Hilden, Germany), as per manufacturer’s protocol
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Table 2. Primers used for reverse transcription-quantitative PCR.
S. No. Gene (human) Forward primer (5′-3′) Reverse primer (5′-3′)
1. OC AAAAAGGCATGAGGGGTCGT CATGGTGTCGAGGAGCTTCA
2. ANGPT1 TGGCTTGGATGTGCAACCT GTTTCCTCTCTGTGTGACCGT
3. RPLP1 CATTCTGCACGACGATGAGG AACAAGCCAGGCCAAAAAGG
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Figure 1. Characterization of umbilical cord mesenchymal stem cells. (A) ALP staining, (B) Oil Red O staining, (C) Alcian blue staining, (D)
characterization of mesenchymal stem cells’ marker proteins by FACS analysis, and characterization of induced endothelial cells: (E)
Matrigel assay, and (F) lectin staining.
FACS: Fluorescence-activated cell sorting.
with a simple modification as described by our group previously [28]. After 3 weeks in culture, 500 μl of TRIzol
were directly added to cell-laden silk scaffolds and homogenized using a pipette tip. The RNA concentration was
determined by measuring absorbance at 260 nm using BioDrop Duo (UK).
A reverse transcription reaction was performed with 1 μg pure total RNA using the QuantiTect Reverse
Transcription Kit (Qiagen) according to the manufacturer’s instructions. qPCR measurements of gene expression
for osteogenic (OC: osteocalcin) and angiogenic marker (ANGPT1: angiopoietin1) were performed using a CFX96
Real-Time PCR Detection System (Bio-Rad Laboratories, CA, USA; Table 2). iTaq Universal SYBR Green Supermix
(Bio-Rad Laboratories) was used for the reaction. The target gene expressions were normalized to that of the
endogenous reference (RPLP1: Ribosomal Protein Lateral Stalk Subunit P1), and relative differences in target gene
expression were determined using the 2-CT method. The normalized expression of each gene in co-cultured 3D
silk scaffolds was expressed relative to the corresponding gene expression in control group A.
Statistical analysis
All statistical comparisons were performed by using one-way analysis of variance test followed by Bonferroni’s
post-hoc test (GraphPad Prism 7, CA, USA). For all analyses, a 95% CI was used, and the results were considered
significant at p < 0.05 level and p < 0.01.
Results
Characterization of UCMSCs & iECs
UCMSCs were successfully differentiated into osteogenic, adipogenic and chondrogenic lineages (Figure 1A, B
& C). Flow cytometric analysis showed that UCMSCs intensively expressed MSC markers while lacking the
hematopoietic and endothelial markers (Figure 1D). iECs produced the typical tube-like structures on Matrigel
(Figure 1E). They also showed positive staining for lectin (Figure 1F).
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Figure 2. Scanning electron microscopy images of silk fibroin nanofiber scaffold. (A & C) and cell attached to the silk
scaffold (B & D). The arrow denotes the adhered cells. Scale bar: (A & B) 10 μm, (C) and (D) 2 μm.
W1
W3
Figure 3. Live dead assay of cells cultured on silk fibroin nanofiber scaffolds at weeks 1 and 3. (A) Mesenchymal
stem cells monoculture; (B) induced endothelial cells–mesenchymal stem cells co-culture and (C) endothelial
cells–mesenchymal stem cells co-culture. Scale bar: 100 μm.
Silk fibroin nanofiber scaffold
Deposition of electrospun SF nanofibers onto the target was achieved by electrospinning at 14 kV. Further, SEM
analysis of SF nanofibers revealed the smooth surface and the nanofibers had diameters in the range of 400–500 nm
(Figure 2). Further, morphological analysis of the nanofiber scaffold exhibited the homogeneous deposition of the
fibers covering the total surface area of target (Figure 2). Furthermore, SEM images (Figure 2) of the scaffolds with
and without cells clearly showed the cell attachment to the silk nanofiber of the scaffold. The cellular process and
spreadings of the attached cells were evident from the images.
Live/dead assay
The fluorescent microscopic pictures (Figure 3) of the live/dead assay showed excellent viability for all three groups
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Figure 4. AlamarBlue assay of cells cultured on silk fibroin nanofiber scaffolds at weeks 1 and 3. (A) Mesenchymal
stem cells monoculture; (B) induced endothelial cell–mesenchymal stem cells co-culture and (C) endothelial
cell–mesenchymal stem cell co-culture.
without substantial dead cells. The cells attached well to the SFNS in all the groups, indicating the good structural
support provided by silk materials (Figure 2).
AlamarBlue assay
The AlamarBlue dye reduction is indicative of cell proliferation. The dye reduction levels correlate positively
with cell proliferation. The AlamarBlue reduction test showed good levels of cell proliferation for all the groups
(Figure 4). No significant difference was observed between the groups.
Differentiation studies
ALP assay & staining
The measured ALP activity was normalized to the total protein content. Compared with the control group A,
group B showed significantly higher (p < 0.05) ALP values at week 3 (Figure 5A). Also, group C (p < 0.05)
expressed higher ALP levels than group A at week 3. The ALP-stained pictures complied well with the assay results
(Figure 5B).
Calcium assay & staining
The calcium deposition followed the same pattern as ALP assay (Figure 6A). Group B expressed significantly higher
(p < 0.05) calcium levels than the control group A at week 3. Also, values of group C were significantly higher (p
< 0.05) than the control group A at week 3. Scaffolds stained with Alizarin Red corroborated with the results of
calcium assay (Figure 6B).
Gene studies
RT-qPCR analysis (at week 3) confirmed the differentiation and expression of the osteogenic marker molecule OC
and angiogenic marker molecule ANGPT1 in the co-culture groups (Figure 7). The co-culture groups showed a
strong expression of OC in comparison to the control group A. The induced co-culture group B showed higher
OC expression than MSC monoculture. The expression of ANGPT1 was observed to be higher in groups B and C
as compared with the monoculture group A.
Discussion
Resulting data have shown that iECs can play the role of ECs in a co-culture with UCMSCs on a silk nanofiber
scaffold. It is also evident that the osteodifferentiation of MSC–iEC co-cultures is far superior to MSC monocultures.
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Figure 5. ALP assay and staining. (A) ALP assay of cells cultured on silk fibroin nanofiber scaffolds at weeks 1 and 3.
The differences are considered significant at *p < 0.05. (B) ALP staining of cells cultured on silk fibroin nanofiber
scaffolds at weeks 1 and 3. (A) Mesenchymal stem cell monoculture; (B) induced endothelial cells–mesenchymal stem
cells co-culture and (C) endothelial cells–mesenchymal stem cells co-culture.
Scale bar: 100 μm.
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Figure 6. Calcium assay and staining. (A) Calcium assay of cells cultured on silk fibroin nanofiber scaffolds at weeks 1
and 3. The differences are considered significant at *p < 0.05. (B) Alizarin Red staining of cells cultured on silk fibroin
nanofiber scaffolds at weeks 1 and 3. (A) Mesenchymal stem cell monoculture; (B) induced endothelial
cells–esenchymal stem cells co-culture and (C) endothelial cells–mesenchymal stem cells co-culture.
Scale bar: 100 μm.MSC: Mesenchymal stem cell.
In this study, we have used two different co-culture groups to understand the role of endothelial differentiation of
MSCs in overall osteodifferentiation in a silk-based scaffold when in a co-culture model.
Bone tissue engineering, based on stem cells and biomaterials, may provide a chance of reconstructing the lost
bone tissue. These cells should be committed to the osteogenic lineage for the implant to be able to fill bone
defects. It is established that MSCs play a vital role in bone tissue regeneration and can create a regenerative
microenvironment [30]. Because of their differentiation capacity, MSCs prove to be promising candidates for tissue-
engineering applications. UCMSCs were found to be viable, and they were not rejected even after 4 months of
transplantation as xenografts, suggesting these cells to be a promising cell source for transplantation [26,31].
The notion of using co-culture of MSCs with ECs seems to be promising for bone-regeneration applications [5].
The MSC–EC interaction may have a profound effect on proliferation, differentiation, cell fate and consequent
angiogenesis and osteogenesis [6]. Direct contact of human ECs and MSCs has shown to increase the mineralization
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Figure 7. Real time PCR analysis of cells cultured on silk fibroin nanofiber scaffolds at week 3 for Angiopoietin 1
and osteocalcin. (A) Mesenchymal stem cell monoculture; (B) induced endothelial cells–mesenchymal stem cell
co-culture and (C) endothelial cells–mesenchymal stem cell co-culture.
and ALP activity (an early osteogenic marker) both in vitro and in vivo [32–35]. In addition, Sun et al. reported
that MSC–EC co-culture improved bone formation and blood perfusion of the transplanted constructs [11].
Gershovich et al. established that co-culturing osteogenically precultured MSCs with HUVECs in a 1:1 ratio-
enhanced osteogenic differentiation compared with MSC cultures alone. They showed that the ALP levels in
co-cultures were higher than that of monocultures. They also observed the higher production of collagen and
glycosaminoglycans [12]. This accentuates the role of ECs as osteogenic mediators in co-culture systems.
Most of the times, ECs are isolated from large blood vessels, which are then seeded, in a suitable scaffold. Although,
these ECs have several drawbacks, including low proliferation rate in culture, lack of availability of large vessels
and the tendency to de-differentiate in culture after three passages [18,27,36]. Previous co-culture studies used MSCs
and ECs obtained from two different sources or even species, which restricted potential clinical applications [20,37].
Endothelial progenitor cells, which can differentiate into mature ECs both in vitro and in vivo, have also been
employed as EC source [38]. However, these cells have the disadvantage of limited proliferation capacity and losing
their characteristics after prolonged expansion [39,40]. Hence, there is a need for an alternative source of ECs.
The cells isolated from human umbilical cord are indicative of mesoangioblasts in phenotype, which were
mesenchymal-like cells primarily related to the walls of large vessels. They were found to differentiate into both
mesodermal and endothelial lineages, and also expressed EC markers [41,42]. Another explanation is that pluripotent
MSCs were found in early phase mesoderm and ectoderm, making it possible for them to differentiate into mesoderm
and ectoderm lineages. Since ECs belong to mesoderm lineage, it is safe to say that MSCs can transdifferentiate
into endothelial lineage [43].
Endothelial differentiation of MSCs has been reported earlier by many groups [12,18,19,44,45]. Alaminos et al.
showed that endothelial differentiation of MSCs resulted in expression of high levels of VEGFR1, CD36 and
endothelin converting enzyme 2 that were similar to that of HUVECs. They reported that the receptor profile of
the differentiated MSCs matched HUVECs and was clearly different from the MSC profile [23]. MSCs subjected to
endothelial differentiation functioned similarly to HUVECs in Matrigel sprouting assay [13]. Tao et al. also showed
that endothelial differentiation of MSCs leads to the similar expression of von Willebrand factor (vWF) and CD
31 as that of HUVECs [20].
Endothelial differentiation of MSCs was achieved by growing MSCs in EC growth medium for few days.
The time of induction varied from one week to two weeks. Some carried out the endothelial differentiation of
MSCs for seven days [21], while some for ten days [13], and others for 12 days [10], and 14 days [20]. The initial
cell density of seeded MSCs also differed among studies from 3000 to 5000 cells/cm2. While Portalska et al.
used 3000 cells/cm2 [13] Chen’s group used 5000 cells/cm2 [10]. Most of the studies used EGM-2 for endothelial
induction [12,19], but few others used a basal medium with VEGF [21] and also including other factors such as
epidermal growth factor and hydrocortisone with VEGF [10].
Another significant factor is the source of MSCs, which were differentiated into endothelial phenotype. Most
of the studies used BM-MSCs for endothelial differentiation [12,19,30,44]. Although, it was reported that UCMSCs
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were more favorable for neovascularization of engineered tissues than BM-MSCs [10,46]. UCMSCs expressed higher
levels of endothelial-specific markers such as von Willebrand factor, Flk-1 and VE-cadherin than BM-MSCs after
endothelial induction. Also, UCMSCs had higher tubule diameter, length and area than BM-MSCs following
endothelial differentiation.
Tao et al. have reported the use of iECs in co-culture with MSCs [20]. Although they found the ALP activity of
MSC/iEC co-cultures to be higher than MSC monocultures, the study did not dwell into any more detailed assays
or gene expression studies. Also, they used MSCs from bone marrow for their work.
The role of iECs in co-culture with MSCs was also reported by Tao and group. They observed that the activity
of BM-MSC/iEC co-culture group was significantly higher than BM-MSCs alone. However, they did not perform
any comparison of iEC co-cultures with EC co-cultures. Most of the previous studies have tested the endothelial
differentiation of MSCs under 2D culture conditions [17,18,30,45]. Very few groups have studied this endothelial
differentiation on β-tricalcium phosphate and poly-L-lactide/poly(lactic-co-glycolic acid) scaffolds [12,19]. But these
studies do not dwell on the role of iECs in co-culture in detail. We have reported the comparison of co-cultures
regarding endothelial differentiation of MSCs with the traditional MSC co-cultures and monoculture, which is
unique. It has been observed that MSCs interact and attract to in vitro formed vascular structures [47].
Lozito et al. observed the tendency of MSCs to differentiate toward endothelial and smooth muscle lineages
upon changing the matrix composition and crosslinking level [48]. It was also reported that MSCs cultured on
Matrigel, a basement membrane matrix showed higher expression of KDR, which stimulated them to differentiate
into endothelial lineage [13]. Thus, there is a great need for appropriate structural scaffold and scalable source of ECs
supporting the osteogenic induction of MSCs. Various fabrication techniques have been employed to reconstruct
the natural extracellular matrix (ECM) of bone tissue. Especially, 3D scaffolds constructed by electrospinning serve
as promising bone tissue-engineering scaffolds due to their simulation of natural ECM structures, high surface area
and porosity [24,40,49]. To address some of these problems, we have fabricated silk fibroin nanofibrous scaffold and
studied its ability for supporting the osteogenic differentiation of MSC–ECs co-cultures.
Silk fibroin is a widely known natural biomaterial acquired from B. mori cocoons and contains alanine, glycine
and serine [42,43]. Previous reports have shown that silk fibroin has excellent biocompatibility, strong mechanical
properties and low degradation rate [50–52]. BM-MSCs produced new ECM on patterned silk fibroin surfaces [53].
Silk fibroin supported BM-MSC adhesion and proliferation required for bone regeneration [54]. Electrospun 3D
silk fibroin scaffolds enhanced the preosteoblast proliferation and ALP activity of the osteoblasts [55,56].
In this study, we have used one single MSC source to get MSC–EC co-culture and compared it with the
two-source MSC–EC co-culture. iECs were produced and their functional capacity was assessed for inducing the
osteogenic differentiation of MSCs within the SFNS. Our study differs from the previously published work due to
the types of cells used, methodology and application. For instance, Alaminos et al. transdifferentiated Wharton’s
jelly stem cells to endothelial-like stem cells for use in vascular tissue engineering [23]. Portalska’s group established
a protocol for endothelial differentiation of human mesenchymal stromal cells [13]. The aim of our study is based
on the use of autologous cells for two different cell types, which varies differently from the other studies wherein
their major concern is to address the vascular tissue-engineering applications [57,58].
FDA/PI staining showed satisfactory live cell attachment on 2D culture plate as well as the 3D silk nanofiber
scaffolds. This was observed in both MSC monoculture and co-culture groups at weeks 1 and 3 time points.
Silk nanofiber scaffolds served as a good support for the cell attachment. The proliferation rate of both MSC
monoculture and co-culture was higher on 2D culture plate as compared with the electrospun silk fibroin scaffolds
at weeks 1 and 3. Since the process of MSC differentiation marks a dip in cell proliferation [59], it is deduced that
MSC differentiation is higher on silk scaffolds than the 2D plate. Also, higher osteogenic differentiation as seen
by ALP staining, was higher on 3D silk scaffolds. Hence, silk nanofiber scaffolds were seen to be better for cell
proliferation and osteogenic differentiation as compared with the 2D culture plate (Supplementary Figure 1–3).
In the present study, iECs obtained from endothelial induction of UCMSCs showed tube-like formation in
Matrigel and stained positively for lectin. The tube formation in the Matrigel and the positive expression of lectin
are characteristic attributes of ECs. The MSCs were successfully characterized by the trilineage differentiation of
the UCMSCs, combined with the positive expression of the MSC markers. The attachment of cells on the silk
nanofiber scaffolds was confirmed by the SEM images. The cell viability was seen from the images of FDA/PI assay.
The green-labeled viable cells were clearly evident in all the groups. The AlamarBlue results showed that the cells of
all groups proliferated well. The dye reduction of the groups is indicative of their proliferation. Hence, it is deduced
that the cells of all groups possessed good proliferation capacity. The SFNS consisted of a cover glass of 13 mm
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diameter upon which the silk fibroin nanofibers were deposited. Due to the limited space on the scaffold and the
long duration of 3 weeks, the cells might have been over confluent, which has been shown to cause cell death [60].
Although, the cells viability seems to be lower at week 3, good cell proliferation was seen in the AlamarBlue assay
at week 3. Also, the supplementary results of live–dead assay prove that the silk nanofiber scaffold serves as good
support for the cell attachment.
The ALP activity clearly showed the osteogenic differentiation to be higher for iEC-based co-culture group as
compared with the monoculture group A and was proximal to the EC-based co-culture group. Both the ALP assay
and ALP staining showed the same trend. The calcium assay and the calcium staining showed that the calcium levels
were higher for iEC-based co-culture group as compared with the MSC monoculture group A and were proximal
to the EC-based co-culture group. The 3D scaffolds used for the study were thin and porous 3D nanofibrous
scaffolds. Hence, the light was partly permeable and the seeded cells could be imaged and the deposited calcium
could be stained as mentioned in the methods section without any problem. Hence, just the incorporation of
iECs into MSC culture resulted in higher osteogenic differentiation. Since iECs are obtained from UCMSCs,
one single source of MSCs can be used to get two different kinds of cells, which can be co-cultured for the
achievement of enhanced osteodifferentiation. This would help surpass the tedious work of obtaining two different
kinds of cells using different isolation protocols with difficult ethical approval for two cell source samples. Since
it requires just 12 days of endothelial induction of UCMSCs, UCMSC/iEC co-culture is an easy and superior
choice over the conventional MSC/EC co-culture. This proves the role of iECs in co-culture with MSCs to induce
osteodifferentiation.
Meinel et al. reported enhanced bone formation potential when MSCs were predifferentiated toward osteoblastic
lineage [8]. Binder and group also reported increased cell survival when cells were precultured in osteogenic
medium [9]. As few such reports suggested the predifferentiation of MSCs for better bone formation [61,62], we
added a predifferentiated MSC co-culture group in the study. However, there was no significant difference of
osteogenic differentiation seen between predifferentiated MSC co-culture group and nonpredifferentiated MSC
(data not shown). Therefore, it was deduced that osteogenic differentiation of MSCs before co-culture does not
have any effect on their metabolic activity, which has been reported earlier [63,64]. This shows that osteogenic
preinduction of MSCs before co-culture did not help in increase of osteogenic differentiation.
To establish that iECs can act as a substitute for ECs, we checked the expression of the angiogenic marker,
Angiopoietin-1, in all the co-culture groups [65,66]. Angiopoietin-1 acts as a chemoattractant for ECs during
angiogenesis, and also EC sprouting [67]. The results positively demonstrate that the iECs highly express angiogenic
markers in co-culture with MSCs. Osteocalcin (also known as BGLAP) is a middle-to-late osteogenic marker, mainly
expressed by late osteoblasts and osteocytes [68]. It plays a significant role in mineralization of the bone tissue [69].
The OC gene expression trend in the co-culture groups is supported by the observations made in the Alizarin Red
staining for calcium deposition. Although the iEC-based group: group B shows lower gene expression as compared
with the EC-based groups: group C, its expression is still higher than the monoculture control group A. Hence,
it is noteworthy that the usage of one cell source for co-culture can increase the osteogenic and endothelial gene
expression as compared with its application as a monoculture.
Our study shows the intelligent use of one source of MSCs to obtain two cell types, which on co-culture, attain
higher osteogenic differentiation than culturing MSCs alone. In addition to the previous findings, we have also
proved that iECs play the role of ECs when co-cultured with MSCs. Osteogenic preinduction of MSCs before
co-culture did not favor osteogenic differentiation. In the future, autologous MSCs for the development of co-
cultures would be of great help for use in personalized medicine. One type of cell, that is, MSC from the patient
can give rise to iECs, which can be co-cultured with primarily obtained MSCs to form bone. This method of bone
formation can be further translated into various new technologies for bone tissue-engineering applications.
Conclusion
We have compared the osteogenic differentiation of isogenic iEC–MSC co-cultures to that of UCMSC monoculture
and EC–MSC co-culture. We found that iEC-based co-culture showed similar osteogenic differentiation to that
of EC–MSC-based co-culture. This proved that iECs are mimicking ECs when co-cultured with MSCs. We show
that one MSC source can be used to give rise to both MSCs and iECs. Thus, isogenic MSCs and iECs on SFNS
hold potential for bone tissue engineering (Figure 8).
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Figure 8. Isogenic induced-endothelial cells enhance osteogenic differentiation of mesenchymal stem cells on silk
fibroin scaffold.
EC: Endothelial cell; iEC: Induced endothelial cell; SFNS: Silk fibroin nanofiber scaffold; UCMSC: Umbilical cord
mesenchymal stem cells.
Translational perspective
Future directions toward the successful development of autologous cells for personalized medicine would be a great
milestone to reach. MSCs procured from the patient can be used to create iECs, which when co-cultured with
MSCs have the ability to form a bone-like matrix. Sophisticated methods like 3D bioprinting can also be used
to form bone that can then be transplanted back into the patient avoiding any problems of tissue rejection or
ethical issues. Owing to the multiple cell types, matrix components and their organization, it becomes difficult to
grow a living tissue or organ in their native state. Besides being used to replace damaged organs, the 3D constructs
produced by tissue engineering can also be used as experimental platforms. The 3D bioprinting is a promising
approach for tissue regeneration and remains a transformative tool in several fields. With advanced technology and
increased accessibility, the process should be well improved to develop fully functional, ready-to-implant constructs
in the coming years.
Supplementary data
To view the supplementary data that accompany this paper please visit the journal website at: www.futuremedicine.com/doi/full/
10.2217/rme-2018-0166
Acknowledgments
The authors would like to thank V Swarnalatha for assistance with scanning electron microscopy images.
Financial & competing interest disclosure
The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or finan-
cial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria,
stock ownership or options, expert testimony, grants or patents received or pending, or royalties.
No writing assistance was utilized in the production of this manuscript.
Ethical conduct of research
All procedures performed in studies involving human participants were in accordance with the ethical standards of the Institutional
Ethics Committee and Institutional Committee for Stem Cell Research of IIT Hyderabad and with the 1964 Helsinki declaration and
its later amendments or comparable ethical standards. In addition, for investigations involving human subjects, informed consent
has been obtained from the participants involved.
10.2217/rme-2018-0166 Regen. Med. (Epub ahead of print) future science group
Isogenic-induced endothelial cells as a new option Research Article
Open access
This work is licensed under the Attribution-NonCommercial-NoDerivatives 4.0 Unported License. To view a copy of this license,
visit http://creativecommons.org/licenses/by-nc-nd/4.0/
Summary points
• Direct interaction of endothelial cells (ECs) with mesenchymal stem cells (MSCs) results in the osteogenic
differentiation of MSCs in vitro and in vivo. Induced ECs (iECs) were produced by endothelial differentiation of
MSCs and co-cultured with MSCs on silk fibroin nanofiber scaffolds (SFNS).
• Previous studies did not dwell into any detailed assays or gene expression studies. Also, they used MSCs from
bone marrow for their work and did not perform any comparison of iEC co-cultures with EC co-cultures.
• In this study, we investigated the role of iECs in MSCs/iECs co-culture and assessed their osteogenic ability in
comparison with MSCs monoculture and MSCs/ECs co-culture on SFNS. We have reported the comparison of
co-cultures regarding endothelial and osteogenic differentiation of MSCs, which is unique.
• ALP levels and calcium deposition of the co-cultures containing iECs were found to be higher than the
monoculture MSCs group and proximal to the co-cultures containing ECs. Furthermore, it is noteworthy that the
usage of isogenic iECs for co-culture can increase the osteogenic and endothelial gene expression.
• These findings suggest that iECs mimic ECs when co-cultured with MSCs and exert their osteogenic potential.
Thus, we show that one MSCs source can be used to give rise to both MSCs and iECs for osteogenic interactions.
The resulting isogenic MSCs/iECs co-culture system provides a new option for bone tissue-engineering
applications, and SFNS holds potential as a supporting scaffold.
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